In a patient who recently underwent coronary artery bypass graft (CABG) surgery, will a myocardial infarction (MI) still present with a typical ST‑segment elevation myocardial infarction (STEMI) distribution on the electrocardiogram (EKG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

EKG Presentation of MI in Recent CABG Patients

Post-CABG patients frequently have baseline ECG abnormalities that complicate the interpretation of typical STEMI patterns, and when MI does occur, it may not present with classic ST-segment elevation distributions.

Key ECG Considerations in Post-CABG Patients

Baseline ECG Abnormalities Are Common

  • More than 30% of post-CABG patients have resting ECG abnormalities, making standard ECG interpretation less reliable 1.
  • New ST-T abnormalities are common after cardiac surgery, even without MI 2.
  • ST-segment elevation not due to perioperative MI occurs in approximately 12.6% of CABG patients and is not associated with increased morbidity or mortality 3.

Timing Matters: Early vs. Late Post-CABG MI

Within 48 hours of CABG (Type 5 MI):

  • The Third Universal Definition of MI specifies that new pathological Q waves or new LBBB in different territories than pre-surgery should raise suspicion for MI, particularly when combined with elevated biomarkers, new wall motion abnormalities, or hemodynamic instability 2.
  • Biomarkers cannot stand alone in this setting due to expected post-surgical elevation 2.
  • MRI studies suggest most necrosis is diffuse and subendocardial rather than focal, which may not produce typical STEMI patterns 2.

Beyond 48 hours post-CABG:

  • Standard MI criteria apply 2.
  • The culprit vessel determines ECG presentation.

Culprit Vessel Determines ECG Distribution

Saphenous Vein Graft (SVG) Occlusion (Most Common)

  • SVG disease is responsible for MI in 76% of post-CABG patients presenting with acute coronary syndrome 4.
  • SVG occlusions may produce atypical or absent ST-segment elevation because:
    • Grafts often supply territories different from native coronary distributions
    • Large thrombus burden (often >2 cm) may cause diffuse rather than focal ischemia 4
    • Collateral circulation from other grafts may modify the ECG pattern

Native Vessel Occlusion

  • When the native vessel is the culprit (16% of cases), more typical STEMI distributions may be seen 4.
  • However, prior MI, surgical scarring, and altered anatomy can still obscure classic patterns 1.

Clinical Implications and Diagnostic Approach

Don't Rely on ECG Alone

  • There should be a low threshold for angiography in post-CABG patients with suspected MI due to ECG limitations and multiple anatomic possibilities 1, 5.
  • ECG stress tests are less conclusive in post-CABG patients 1.
  • Myocardial stress perfusion imaging and dobutamine echocardiography are often more helpful diagnostically 1.

Important Pitfalls

  • Post-CABG patients with STEMI have worse angiographic outcomes (TIMI 3 flow achieved in only 82.5% vs. 91.6% in non-CABG patients) 6.
  • When the infarct-related artery is a bypass graft rather than native vessel, outcomes are significantly worse (19% vs. 5.7% 90-day mortality) 6.
  • Conventional intravenous thrombolytic therapy may be inadequate for SVG occlusions due to large thrombus burden, potentially requiring subselective infusion or mechanical intervention 4.

Risk Stratification

  • Post-CABG patients presenting with MI are at higher risk with more extensive CAD and LV dysfunction than non-CABG patients 1.
  • They have twice the incidence of adverse events (death, MI, or recurrent ischemia) at one year compared to non-CABG patients 1.

References

Guideline

third universal definition of myocardial infarction.

Journal of the American College of Cardiology, 2012

Related Questions

What are the recommended loading doses of antiplatelet and anticoagulant agents for a patient presenting with ST-elevation myocardial infarction (STEMI)?
What is the cardiac risk and recommended peri‑operative management for a patient undergoing non‑cardiac surgery after a ST‑segment elevation myocardial infarction (STEMI)?
In a patient who is in cardiac arrest (coding) with a confirmed ST‑segment‑elevation myocardial infarction (STEMI), should tissue plasminogen activator (tPA, alteplase) be administered?
What are the management strategies for EKG (electrocardiogram) changes in patients post coronary artery bypass grafting (CABG) surgery?
Can Anoro (umeclidinium and vilanterol) be used safely in a patient with a history of myocardial infarction (MI) and coronary artery bypass grafting?
What cardiac side effects can occur with intravenous magnesium administration?
What is bradycardia and will switching from metoprolol to Bystolic (nebivolol) cause a slower heart rate?
What is the typical increase in heart rate (tachycardia) after a standard dose of albuterol?
When is mannitol indicated in acute posterior circulation ischemic stroke, and what is the recommended dose and monitoring?
What is the recommended starting dose of lorazepam for alcohol withdrawal syndrome in adults, and how should it be adjusted for elderly patients or those with hepatic impairment?
What is the appropriate emergency management for an adult with diabetic ketoacidosis and altered mental status (Glasgow Coma Scale ≤ 8)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.